📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation. (2017)

First Author: Barker G

Attributed to: The Cyclic AMP-GEF/C/EBP Pathway; a New PKA-independent Route for the Control of Gene Expression by Cyclic AMP funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/jcdd4040022

PubMed Identifier: 29367551

Publication URI: http://europepmc.org/abstract/MED/29367551

Type: Journal Article/Review

Volume: 4

Parent Publication: Journal of cardiovascular development and disease

Issue: 4

ISSN: 2308-3425